Document Type

Oral Presentation

Location

Oxford Conference Center, Oxford MS

Event Website

https://oxfordicsb.org/

Start Date

8-4-2025 10:00 AM

Description

Over the last decade, ashwagandha (Withania somnifera (L.) Dunal, AS) has been brought under increasing scrutiny regarding its safety for the use in food supplements, culminating in a recent recommendation for an Article 8 procedure according to Regulation (EC) No 1925/2006 in the European Union (EU). Once executed, this could lead to a ban of the use as an ingredient in food supplements. One of the regulators’ concerns is the purported lack of clinical safety data combined with evidence for what may constitute a safe daily dose. In this overwiew we assess evidence stemming from 96 clinical trials conducted over a period of 45 years for what can be considered safe dosing, recorded adverse events, and physiological effects of concern.

Publication Date

April 2025

Accessibility Status

Screen reader accessible, Searchable text

Download

Share

COinS
 
Apr 8th, 10:00 AM

Ashwagandha: is it safe? A review of the clinical evidence.

Oxford Conference Center, Oxford MS

Over the last decade, ashwagandha (Withania somnifera (L.) Dunal, AS) has been brought under increasing scrutiny regarding its safety for the use in food supplements, culminating in a recent recommendation for an Article 8 procedure according to Regulation (EC) No 1925/2006 in the European Union (EU). Once executed, this could lead to a ban of the use as an ingredient in food supplements. One of the regulators’ concerns is the purported lack of clinical safety data combined with evidence for what may constitute a safe daily dose. In this overwiew we assess evidence stemming from 96 clinical trials conducted over a period of 45 years for what can be considered safe dosing, recorded adverse events, and physiological effects of concern.

https://egrove.olemiss.edu/icsb/2025_ICSB/Schedule/14